These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 7496564)

  • 1. Normalization of structural cardiovascular changes during antihypertensive treatment with a regimen based on the ACE-inhibitor perindopril.
    Sihm I; Schroeder AP; Aalkjaer C; Holm M; Mørn B; Mulvany M; Thygesen K; Lederballe O
    Blood Press; 1995 Jul; 4(4):241-8. PubMed ID: 7496564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Normalization of resistance artery structure and left ventricular morphology with a perindopril-based regimen.
    Sihm I; Schroeder AP; Aalkjaer C; Holm M; Mørn B; Mulvany M; Thygesen K; Pedersen OL
    Can J Cardiol; 1994 Nov; 10 Suppl D():30D-32D. PubMed ID: 7954038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regression of media-to-lumen ratio of human subcutaneous arteries and left ventricular hypertrophy during treatment with an angiotensin-converting enzyme inhibitor-based regimen in hypertensive patients.
    Sihm I; Schroeder AP; Aalkjaer C; Holm M; Mørn B; Mulvany M; Thygesen K; Lederballe O
    Am J Cardiol; 1995 Nov; 76(15):38E-40E. PubMed ID: 7484887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of isradipine and spirapril on left ventricular hypertrophy and resistance arteries.
    Thürmann PA; Stephens N; Heagerty AM; Kenedi P; Weidinger G; Rietbrock N
    Hypertension; 1996 Sep; 28(3):450-6. PubMed ID: 8794832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of antihypertensive treatment on cardiac and subcutaneous artery structure: a comparison between calcium channel blocker and thiazide-based regimens.
    Sihm I; Schroeder AP; Aalkjaer C; Mulvany MJ; Thygesen K; Lederballe O
    Am J Hypertens; 1998 Mar; 11(3 Pt 1):263-71. PubMed ID: 9544865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term renal and cardiovascular effects of antihypertensive treatment regimens based upon isradipine, perindopril and thiazide.
    Sihm I; Thygesen K; Krusell LR; Lederballe O
    Blood Press; 2000; 9(6):346-54. PubMed ID: 11212064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ambulatory blood pressure and left ventricular changes during antihypertensive treatment: perindopril versus isradipine.
    Grandi AM; Bignotti M; Gaudio G; Zanzi P; Guasti L; Venco A
    J Cardiovasc Pharmacol; 1995 Nov; 26(5):737-41. PubMed ID: 8637188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myocardial perfusion during long-term angiotensin-converting enzyme inhibition or beta-blockade in patients with essential hypertension.
    Buus NH; Bøttcher M; Jørgensen CG; Christensen KL; Thygesen K; Nielsen TT; Mulvany MJ
    Hypertension; 2004 Oct; 44(4):465-70. PubMed ID: 15326083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Value of rilmenidine therapy and its combination with perindopril on blood pressure and left ventricular hypertrophy in patients with essential hypertension (VERITAS).
    Farsang C; Lengyel M; Borbás S; Zorándi A; Dienes BS;
    Curr Med Res Opin; 2003; 19(3):205-17. PubMed ID: 12803735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of long-term antihypertensive treatment with lisinopril on resistance arteries in hypertensive patients with left ventricular hypertrophy.
    Rizzoni D; Muiesan ML; Porteri E; Castellano M; Zulli R; Bettoni G; Salvetti M; Monteduro C; Agabiti-Rosei E
    J Hypertens; 1997 Feb; 15(2):197-204. PubMed ID: 9469796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relation between peripheral vascular structure, left ventricular hypertrophy, and ambulatory blood pressure in essential hypertension.
    Sihm I; Schroeder AP; Aalkjaer C; Holm M; Mørn B; Mulvany M; Thygesen K; Lederballe O
    Am J Hypertens; 1995 Oct; 8(10 Pt 1):987-96. PubMed ID: 8845080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of blood pressure in spontaneously hypertensive rats after withdrawal of long-term treatment related to vascular structure.
    Christensen KL; Jespersen LT; Mulvany MJ
    J Hypertens; 1989 Feb; 7(2):83-90. PubMed ID: 2522478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Course of the left ventricular mass in a population of 893 hypertensive patients. Effects of treatment with perindopril].
    Revel F; Gallois H; Le Coz Y; Richard R; Ollivier JP
    Ann Cardiol Angeiol (Paris); 1994 Dec; 43(10):594-9. PubMed ID: 7864552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of antihypertensive treatment on small arteries of patients with previously untreated essential hypertension.
    Thybo NK; Stephens N; Cooper A; Aalkjaer C; Heagerty AM; Mulvany MJ
    Hypertension; 1995 Apr; 25(4 Pt 1):474-81. PubMed ID: 7721386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coronary reserve in experimental myocardial hypertrophy.
    Gosse P; Clementy J
    Eur Heart J; 1995 Aug; 16 Suppl I():22-5. PubMed ID: 8829953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reducing pulse pressure in hypertension may normalize small artery structure.
    Christensen KL
    Hypertension; 1991 Dec; 18(6):722-7. PubMed ID: 1835958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac hypertrophy, aortic compliance, peripheral resistance, and wave reflection in end-stage renal disease. Comparative effects of ACE inhibition and calcium channel blockade.
    London GM; Pannier B; Guerin AP; Marchais SJ; Safar ME; Cuche JL
    Circulation; 1994 Dec; 90(6):2786-96. PubMed ID: 7994822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. No persistent effect of angiotensin converting enzyme inhibitor treatment in Milan hypertensive rats despite regression of vascular structure.
    Mulvany MJ; Persson AE; Andresen J
    J Hypertens; 1991 Jul; 9(7):589-93. PubMed ID: 1653793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of perindopril on cardiovascular remodeling.
    McVeigh GE
    Am J Cardiol; 2001 Oct; 88(7A):28i-35i. PubMed ID: 11591358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of crossing over hypertensive patients from a beta-blocker to an angiotensin receptor antagonist on resistance artery structure and on endothelial function.
    Schiffrin EL; Park JB; Pu Q
    J Hypertens; 2002 Jan; 20(1):71-8. PubMed ID: 11791028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.